Senior insider sale
President and CEO at AMBRX BIOPHARMA, INC. — senior position signals high conviction
$491.2K
50.01K shares
What this filing means
O'CONNOR DANIEL J. plans to sell 50.01K shares of AMBRX BIOPHARMA, INC. valued at approximately $491.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/1/2023ACC: 0001970051-23-000019
DirectorOfficer· President and CEO
Since Oct 2023
50.01K
Shares to sell
$491.2K
Approx. market value
50.01K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
RESTRICTED STOCK UNIT COMMON STOCK
COMPENSATORY PAYMENT
10/27/2023
50.01KTotal acquired50.01K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/27/2023 | RESTRICTED STOCK UNIT COMMON STOCK COMPENSATORY PAYMENT | 50.01K | — |
| Total | 50.01K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
50.01K
Market value
$491.2K
10/27/2023
Total
Units
50.01K
Value
$491.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
10/27/2023 | 50.01K | $491.2K | NASDAQ | Planned |
| Total | 50.01K | $491.2K | ||